Current Report Articles
RSV Vaccine – A New Maternal Indication Brief Webinars

Webinar2 (Oct. 6, 2023) – Pfizer's Vaccines U.S. Medical Affairs team is providing brief educational webinars entitled, Pfizer RSV Vaccine – A New Maternal Indication. Beginning this week, these live sessions will be conducted on Tuesdays, Wednesdays and Thursdays. On-demand content will be available soon. Session topics include:

  • RSV burden of disease in infants
  • Mechanism of Maternal Immunization
  • ACIP Recommendations and Clinical Considerations
  • Clinical Trial Data: Safety and Efficacy
  • Question and answer session

Click on the following link for the live schedule and other educational resources: RSV Vaccine Educational Webinars led by Pfizer Vaccines U.S. Medical AffairsContinuing medical education is NOT associated with this event.
--Karen Braman